Literature DB >> 12546653

Structure and mechanism of the oestrogen receptor.

E H Kong1, A C W Pike, R E Hubbard.   

Abstract

We have determined the structures of the oestrogen receptor ligand-binding domain in complex with a range of ligands and with fragments of co-regulator proteins. These structures provide insights into the structural mechanisms underlying the receptor's complex pharmacological properties and how the conformation of the receptor modulates its ability to recruit co-regulators that are necessary for transcriptional activation.

Mesh:

Substances:

Year:  2003        PMID: 12546653     DOI: 10.1042/bst0310056

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  18 in total

1.  A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling.

Authors:  Zhaoyi Wang; Xintian Zhang; Peng Shen; Brian W Loggie; Yunchao Chang; Thomas F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

2.  X-ray structures of progesterone receptor ligand binding domain in its agonist state reveal differing mechanisms for mixed profiles of 11β-substituted steroids.

Authors:  Scott J Lusher; Hans C A Raaijmakers; Diep Vu-Pham; Bert Kazemier; Rolien Bosch; Ross McGuire; Rita Azevedo; Hans Hamersma; Koen Dechering; Arthur Oubrie; Marcel van Duin; Jacob de Vlieg
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

3.  A variant of estrogen receptor-alpha, ER-alpha36 is expressed in human gastric cancer and is highly correlated with lymph node metastasis.

Authors:  Hao Deng; Xuan Huang; Jun Fan; Liubai Wang; Qin Xia; Xiuping Yang; Zhaoyi Wang; Lijiang Liu
Journal:  Oncol Rep       Date:  2010-07       Impact factor: 3.906

4.  Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells.

Authors:  Quan Jiang; Florastina Payton-Stewart; Steven Elliott; Jennifer Driver; Lyndsay V Rhodes; Qiang Zhang; Shilong Zheng; Deepak Bhatnagar; Stephen M Boue; Bridgette M Collins-Burow; Jayalakshmi Sridhar; Cheryl Stevens; John A McLachlan; Thomas E Wiese; Matthew E Burow; Guangdi Wang
Journal:  J Med Chem       Date:  2010-08-26       Impact factor: 7.446

5.  Changes in estrogen receptor-alpha variant (ER-alpha36) expression during mouse ovary development and oocyte meiotic maturation.

Authors:  Bao-Zeng Xu; Sheng-Li Lin; Mo Li; Jia-Qiao Zhu; Sen Li; Ying-Chun Ouyang; Da-Yuan Chen; Qing-Yuan Sun
Journal:  Histochem Cell Biol       Date:  2008-10-28       Impact factor: 4.304

6.  In silico estrogen receptor alpha antagonist studies and toxicity prediction of Melia azedarach leaves bioactive ethyl acetate fraction.

Authors:  Martha Ervina; Mohammad Rizki Fadhil Pratama; Hadi Poerwono; Juni Ekowati; Retno Widyowati; Katsuyoshi Matsunami
Journal:  J Adv Pharm Technol Res       Date:  2021-07-16

7.  The X-ray structure of RU486 bound to the progesterone receptor in a destabilized agonistic conformation.

Authors:  Hans C A Raaijmakers; Judith E Versteegh; Joost C M Uitdehaag
Journal:  J Biol Chem       Date:  2009-04-16       Impact factor: 5.157

8.  Polymorphisms of estrogen receptor beta gene are associated with hypospadias.

Authors:  A Beleza-Meireles; D Omrani; I Kockum; L Frisén; K Lagerstedt; A Nordenskjöld
Journal:  J Endocrinol Invest       Date:  2006-01       Impact factor: 4.256

9.  Quantitative profiles of the mRNAs of ER-alpha and its novel variant ER-alpha36 in breast cancers and matched normal tissues.

Authors:  Yi Zheng; Jing Zhang; Zhen-zhen Xu; Jian-ming Sheng; Xiao-chen Zhang; Hao-hao Wang; Xiao-dong Teng; Xiao-jiao Liu; Jiang Cao; Li-song Teng
Journal:  J Zhejiang Univ Sci B       Date:  2010-02       Impact factor: 3.066

10.  Ligands specify estrogen receptor alpha nuclear localization and degradation.

Authors:  Silvia Kocanova; Mahta Mazaheri; Stéphanie Caze-Subra; Kerstin Bystricky
Journal:  BMC Cell Biol       Date:  2010-12-10       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.